You are here

  • Home
  • Archive
  • Volume 69, Issue 2
  • Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions

Article info

Article menu
Clinical and epidemiological research
Extended report
Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions

Authors

  1. Correspondence to F van den Bosch, University Hospital Gent, Department of Rheumatology, De Pintelaan 185, B-9000 Gent, Belgium; filip.vandenbosch{at}ugent.be
View Full Text

Citation

Van den Bosch F, Manger B, Goupille P, et al
Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions
Annals of the Rheumatic Diseases 2010;69:394-399.

Publication history

  • Accepted September 17, 2009
  • First published October 7, 2009.
Online issue publication 
November 02, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Van den Bosch et al 2010 This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.